Research Labs

Share
Print
and/or
14 Faculty Members found
Human Oncology & Pathogenesis Program
The Vinod Balachandran Lab
Vinod Balachandran, MD
Surgeon scientist Vinod Balachandran develops novel immunotherapies for pancreatic cancer.
Human Oncology & Pathogenesis Program
Chrysothemis Brown, MBBS, PhD
The Brown Lab studies how the tissue environment shapes immune cell fate and function during early life immune development, inflammation, and cancer.
Memorial Hospital Research Laboratories
The Liang Deng Lab
Liang Deng, MD, PhD
Physician-scientist Liang Deng studies poxvirus interface with the immune system and the development of poxviruses as oncolytic and immunotherapy for cancers.
Immunology Program
The Gretchen Diehl Lab
Gretchen Diehl, PhD
The Diehl lab studies how the microbiota and other exogenous factors regulate development and function of the intestinal immune system.
Immunology Program
Michael Glickman Lab
Michael S. Glickman, MD
Physician-scientist Michael Glickman investigates the physiology and pathogenic mechanisms of mycobacteria, including the use of mycobacteria as bacterial cancer therapies.
Human Oncology & Pathogenesis Program
The Alan Hanash Lab
Alan M. Hanash, MD, PhD
Physician-scientist Alan Hanash studies transplant immunology and immune-mediated mechanisms of tissue damage and regeneration.
Human Oncology & Pathogenesis Program
The Katharine Hsu Lab
Katharine C. Hsu, MD, PhD
Physician-scientist Katharine Hsu studies the biology of human natural killer cells and how they contribute to disease processes.
Immunology Program
The Ming Li Lab
Ming Li, PhD
Immunologist Ming Li studies mechanisms of immune regulation, and their relevance to diseases including cancer.
Cancer Biology & Genetics Program
The Massagué Lab
Joan Massagué, PhD
Joan Massagué studies the control of stem cell growth and phenotype in tumor progression, metastasis, and response to therapy.
Memorial Hospital Research Laboratories
The Elli Papaemmanuil Lab
Elli Papaemmanuil, PhD
Molecular geneticist Elli Papaemmanuil performs systematic interrogations of well-annotated clinical trial cohorts in leukemia and cancer to explore how the compound genetic and clonal architecture in patients' leukemias and tumors dictate clinical phenotype, disease progression, and clinical outcomes.